Default Category
-
Steel Street, Teaching Note
Segel, Arthur I; Ginsburgh, Justin; Creo, BenTeaching Note HBS-210034-EFinanceTeaching Note for [210010].Starting at €0.00
-
Polanco, una oportunidad en boga
Segel, Arthur I; Creo, BenCase HBS-210S06FinancePara maximizar su eficacia, los casos de color deben imprimirse en color. Roberto Charvel es un joven graduado de MBA de hacer su primera inversión en bienes raíces personales en su natal Ciudad de México. Charvel está planeando comprar y renovar un edificio de apartamentos de nueve unidad. Es el mercado? ¿Debería vender o arrendar las unidades? ¿Cómo debería manejar otras cuestiones como los diseños arquitectónicos, el proceso de construcción, y...Starting at €8.20
-
Adaptive Platform Trials: The Clinical Trial of the Future
Stern, Ariel D.; Mehta, SarahCase HBS-618025-EService and Operations ManagementIn July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial-an adaptive platform trial-to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. Alexander believed that the standard way in which new cancer drugs were tested-the traditional randomized controlled trial (RCT)-was limited in many ways. While statistically rigorous and s...Starting at €8.20
-
Twine Health, Teaching Note
Huckman, Robert S.; Stern, Ariel D.Teaching Note HBS-618055-EService and Operations ManagementTeaching note for case 615068.Starting at €0.00
-
Maven Clinic: Women's Health in the Digital Age
Stern, Ariel D.; Mehta, SarahCase HBS-620035-EStrategyIn late 2017, Kate Ryder, the founder and CEO of digital women's health telemedicine company Maven Clinic, faced an important decision. Maven offered both a direct to consumer (D2C) product that anyone could use to book virtual appointments with health practitioners across a range of services and specialties for a fee, and an enterprise product-the Maven Family Benefits platform-which it sold to large employers as an employee benefit. Since found...Starting at €8.20
-
Polanco: A Fashionable Opportunity, Teaching Note
Segel, Arthur I; Creo, BenTeaching Note HBS-209005-EFinanceTeaching Note for [209012].Starting at €0.00
-
Polanco: A Fashionable Opportunity
Segel, Arthur I; Creo, BenCase HBS-209012-EFinanceTo maximize their effectiveness, color cases should be printed in color. Roberto Charvel is a young MBA graduate making his first personal real estate investment in his native Mexico City. Charvel is planning to purchase and renovate a nine unit apartment building. Is the market good? Should he sell or lease the units? How should he handle other issues like the architectural designs, the construction process, and the legal process? How should he ...Starting at €8.20
-
Twine Health
Huckman, Robert S.; Stern, Ariel D.; Preble, MatthewCase HBS-615068-EService and Operations ManagementIn late 2014, Dr. John Moore (CEO), Frank Moss (chairman), and Scott Gilroy (CTO) of Twine Health (Twine) had to resolve several challenges that threatened to restrict the widespread dissemination of its sole product, Twine. Twine was a cloud-based platform that enabled patients to create and manage chronic disease treatment plans in conjunction with their primary care providers and specialized coaches. Twine had already enjoyed impressive succes...Starting at €8.20
-
Adaptive Platform Trials: The Clinical Trial of the Future, Teaching Note
Stern, Ariel D.; Mehta, SarahTeaching Note HBS-618048-EEntrepreneurshipThis teaching note provides guidance and recommendations for teaching HBS Case No. 618025, entitled "Adaptive Platform Trials: The Clinical Trial of the Future?"Starting at €0.00
-
Adaptive Platform Trials: The Clinical Trial of the Future (B)
Stern, Ariel D.; Mehta, SarahCase HBS-620001-EEntrepreneurshipThis case provides an update to the (A) case, which introduces students to adaptive platform trials, an ambitious, more efficient type of clinical trial that increases access to therapies. The A case centers on Dr. Brian Alexander's efforts to launch an adaptive platform trial for studying potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. The (B) case provides an update and explores the strategies that Alexander is c...Starting at €5.74